ATLAS fair value
ATLAS has no fair value for this stock today.
abrdn Healthcare Investors stock price today, ATLAS forecast and fair value
Financial Services · Asset Management · NYSE
Prices as of Oct 26, 2026 · USD
ATLAS has no fair value for this stock today.
52%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives abrdn Healthcare Investors a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $19.46 and $21.31; in 9 out of 10, between $17.95 and $23.09. Estimated annual volatility is 28%.
ATLAS does not publish a fair value for HQH right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks HQH has traded between $17.14 and $24.85. Today it is 18.3% below that high and 18% above its low.
On the business: revenue fell 46.5% year over year; it trades at 4.5 times earnings.
Its beta is 0.74: it tends to move less than the market.
abrdn Healthcare Investors is a closed-end healthcare investment fund that seeks long-term capital appreciation by investing primarily in securities of healthcare companies.
Want to see everything about abrdn Healthcare Investors?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
abrdn Healthcare Investors is a closed-end healthcare investment fund that seeks long-term capital appreciation by investing primarily in securities of healthcare companies.
52%: close to a coin flip. In half of the simulated outcomes, HQH ends the month between $19.46 and $21.31.
abrdn Healthcare Investors's market capitalization is $1.1B. Its price-to-earnings (P/E) ratio is 4.5: you pay $4.5 for each $1 of yearly earnings.
Yes. HQH's current dividend yield is 12.17% at today's price ($20.30).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy